RxDoctor Payments Data

Jordan Foreman, MD

Urology · Albuquerque, NMNPI 1982137584

Payments from drug & device makers

What this record shows

This record is dominated by grants: $50,000 of the $60,189 with a category attached, or 83.1%. Boston Scientific accounts for 92.0% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $52,128 and has fallen 92.5% since, to $3,901 in 2025. Among urology clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$60,189in general payments, 2019–2025

Across 81 payments — averaging $743.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$55K
  • Coloplast$3K
  • Olympus Winter & Ibe GmbH$1K

What the payments were for

  • Consulting fees$1,3752%
  • Grants$50,00083%
  • Travel & lodging$5,4499%
  • Food & beverage$3,3656%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific54$55,351
Coloplast25$3,463
Olympus Winter & Ibe GmbH2$1,375

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$60,189 in reported general payments places this provider in the 95th percentile of 46 urology providers in New Mexico.

See all urology providers in New Mexico

Medicare billing

Part B allowed, 2024
$109,440
Medicare patients
225
Services billed
632

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron65$45,036
GemtesaVibegron59$37,067
Tamsulosin Hcl81$1,286
Trospium Chloride18$1,053
Finasteride62$844
Tadalafil17$330
Pentoxifylline11$298
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim20$83

Paid to pharmacies, not to this prescriber.

Other urology in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →